Search results
Citi sets Harmony Biosciences stock to buy with $48 target By Investing.com
Investing.com· 1 day ago(NASDAQ:HRMY) received a Buy rating from a Citi analyst, who set the price target for the company at...
TD Cowen starts Alkermes stock coverage with Buy By Investing.com
Investing.com· 4 days agoThe firm's coverage begins with a positive outlook on the biopharmaceutical company, particularly...
Why Do i Sweat In My Sleep and 5 Ways to Combat It
Time Magazine· 4 days agoIt’s no secret that sleep is important. Getting enough sound sleep every night is one of the cornerstones of physical and mental health. If you’re...
Adderall shortage could affect over 40,000 Americans, CDC warns
United Press International via Yahoo News· 2 days agoThe U.S. Centers for Disease Control and Prevention is warning Americans about a possible shortage...
Can Adderall Help With My Anxiety?
MediaFeed via AOL· 6 days agoAdderall and anxiety: Two things that don’t mix too terribly well. Adderall is a medication used to treat attention-deficit/hyperactivity disorder...
Urgent Need for Policies to Lower Americas' Insomnia Burden
Medscape· 4 days agoA new analysis highlights the high burden of insomnia across the Americas, with about 17% of adults...
Pizza shop in Mount Penn reborn as health food restaurant
Reading Eagle, Pa. via Yahoo News· 3 days agoFor Andrea Amato, eating healthy isn’t about settling for a soul-crushing diet deprived of flavor. “Our idea of healthy is what we’re consuming, not how many calories something is or whether ...
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Average Rating of “Moderate Buy” by Analysts
ETF DAILY NEWS· 5 days agoShares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have received a consensus rating of “Moderate Buy” from the fourteen brokerages that are covering the stock, MarketBeat.com ...
American Trust Sells 187 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
ETF DAILY NEWS· 5 days agoAmerican Trust lowered its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 10.3% in the 4th quarter, according to the company in its most recent filing with the Securities ...
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Given Consensus Recommendation of “Buy” by Brokerages
ETF DAILY NEWS· 2 days agoZevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) has been given an average rating of “Buy” by the six ratings firms that are covering the stock, MarketBeat.com reports. Six equities ...
